In the three years the Affordable Care Act (ACA) has been in effect, approximately 71 million Americans in private health insurance plans received coverage for at least one free preventive healthcare service.
Congress is reviewing the Personalize Your Care Act, bipartisan legislation to provide Medicare and Medicaid coverage for voluntary advance-care planning consultations.
The Centers for Medicare & Medicaid Services reversed its decision to cut Medicare Advantage payments to insurers by 2.2 percent in 2014 and instead agreed to give them a 3.3 percent increase.
Correction on incorrect reporting about the risk of progressive multifocal leukoencephalopathy with the immunomodulatory drug TYSABRI.
With only 17 states and Washington, D.C., currently signed up to run their own health insurance exchanges beginning in October, the majority of states will participate in federal government-run partnerships with the help of a grant program.
A recent study conducted at theUniversity of Alabama at Birmingham shows that the shingles vaccine appears to be safe and effective for those suffering from autoimmune diseases.
Grifols has launched a new study into methods of treatment for Alzheimer’s disease.
Newer hydroxyethyl starch (HES) products with molecular weight of 130kDa and substitution ratios ranging from 0.38 to 0.45 (130/0.38-0.45) have been claimed to be safer than higher molecular weight (200/0.5-0.6) HES products, which were shown to cause acute kidney injury in two randomized trials in patients with sepsis.
The U.S. Food and Drug Administration has instructed manufacturers to add information to the current boxed warning in the labeling of all intravenous immune globulin (IVIG) products, and add a similar standardized boxed warning for all subcutaneous and intramuscular IG products.
A computer model for predicting flu outbreaks weeks in advance has been developed by researchers at Columbia University and the National Center for Atmospheric Research.
The U.S. Food and Drug Administration (FDA) has determined that hydroxyethyl starch (HES) solutions should not be used in critically ill adult patients, including patients with sepsis and those admitted to the intensive care unit (ICU).
The U.S. Food and Drug Administration(FDA) has approved an expanded indication for CSL Behring’s Corifact, factor XIII (FXIII) concentrate (human) to include the perioperative management of surgical bleeding in adult and pediatric patients with congenital FXIII deficiency.